The global zorcaine market is expected to grow at a CAGR of 3.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for dental care and rising awareness about dental care among people. The global zorcaine market is segmented on the basis of type, application, and region. On the basis of type, the global zorcaine market is segmented into articaine and epinephrine 1:100,000; articaine and epinephrine 1:200,000; articaine only; epinephrine only; other types (lidocaines). On the basis of application, it can be divided into hospital use and dental clinic use. Geographically it can be divided into North America (US & Canada), Latin America (Mexico & Brazil), Europe (Germany & France), Asia Pacific (China & Japan) Middle East & Africa (Saudi Arabia).
Global Zorcaine Market By Type(Articaine And Epinephrine 1:100 000 Articainee And Epinephrine 1:200 000 Articainee Only Epinephrine Only Other Types Lidocaines) By Application(Hospital Dental Clinic) And By Region(North America Latin America Europe Asia Pacific Middle East Africa) Forecast From 2021 To 2030.
- Zorcaine is a topical anesthetic that is used to numb the skin and underlying tissue before surgery or other medical procedures.
- Zorcaine has been approved by the FDA for use in adults, children, and infants over 12 months of age for surgical anesthesia of mucous membranes of the mouth, pharynx, larynx, trachea, esophagus and stomach; as well as for topical anesthesia of mucous membranes of the nose and throat; as well as for local infiltration anesthesia in maxillofacial surgery on mucous membranes including those in sinuses; also for dental extraction under general anesthesia when combined with nitrous oxide/oxygen inhalation sedation (nitrous oxide/oxygen inhalation sedation not included).
- The drug was first introduced by Eli Lilly & Co., but it was discontinued in 2009 due to lack of demand from physicians who were reluctant to prescribe it because they felt it had too many side effects such as nausea and vomiting.
Industry Growth Insights published a new data on “Zorcaine(Primacaine) Market”. The research report is titled “Zorcaine(Primacaine) Market research by Types (Articaine and Epinephrine 1:100,000, Articaine and epinephrine 1:200,000), By Applications (Hospital, Dental Clinic), By Players/Companies Septodont, Acteon Pharma”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Zorcaine(Primacaine) Market Research Report
By Type
Articaine and Epinephrine 1:100,000, Articaine and epinephrine 1:200,000
By Application
Hospital, Dental Clinic
By Companies
Septodont, Acteon Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global Zorcaine(Primacaine) Market Report Segments:
The global Zorcaine(Primacaine) market is segmented on the basis of:
Types
Articaine and Epinephrine 1:100,000, Articaine and epinephrine 1:200,000
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Dental Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Septodont
- Acteon Pharma
 Market Overview.svg)
Highlights of The Zorcaine(Primacaine) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Articaine and Epinephrine 1:100,000
- Articaine and epinephrine 1:200,000
- By Application:
- Hospital
- Dental Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Zorcaine(Primacaine) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Zorcaine is a brand name for the medication primacaine. Primacaine is a local anesthetic that numbs the area being treated.
Some of the major players in the zorcaine(primacaine) market are Septodont, Acteon Pharma.
The zorcaine(primacaine) market is expected to register a CAGR of 3.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Zorcaine(Primacaine) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Zorcaine(Primacaine) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Zorcaine(Primacaine) Market - Supply Chain
4.5. Global Zorcaine(Primacaine) Market Forecast
4.5.1. Zorcaine(Primacaine) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Zorcaine(Primacaine) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Zorcaine(Primacaine) Market Absolute $ Opportunity
5. Global Zorcaine(Primacaine) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Zorcaine(Primacaine) Market Size and Volume Forecast by Type
5.3.1. Articaine and Epinephrine 1:100,000
5.3.2. Articaine and epinephrine 1:200,000
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Zorcaine(Primacaine) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Zorcaine(Primacaine) Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Dental Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Zorcaine(Primacaine) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Zorcaine(Primacaine) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Zorcaine(Primacaine) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Zorcaine(Primacaine) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Zorcaine(Primacaine) Demand Share Forecast, 2019-2026
9. North America Zorcaine(Primacaine) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Zorcaine(Primacaine) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Zorcaine(Primacaine) Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Dental Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Zorcaine(Primacaine) Market Size and Volume Forecast by Type
9.7.1. Articaine and Epinephrine 1:100,000
9.7.2. Articaine and epinephrine 1:200,000
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Zorcaine(Primacaine) Demand Share Forecast, 2019-2026
10. Latin America Zorcaine(Primacaine) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Zorcaine(Primacaine) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Zorcaine(Primacaine) Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Dental Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Zorcaine(Primacaine) Market Size and Volume Forecast by Type
10.7.1. Articaine and Epinephrine 1:100,000
10.7.2. Articaine and epinephrine 1:200,000
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Zorcaine(Primacaine) Demand Share Forecast, 2019-2026
11. Europe Zorcaine(Primacaine) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Zorcaine(Primacaine) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Zorcaine(Primacaine) Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Dental Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Zorcaine(Primacaine) Market Size and Volume Forecast by Type
11.7.1. Articaine and Epinephrine 1:100,000
11.7.2. Articaine and epinephrine 1:200,000
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Zorcaine(Primacaine) Demand Share, 2019-2026
12. Asia Pacific Zorcaine(Primacaine) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Zorcaine(Primacaine) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Zorcaine(Primacaine) Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Dental Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Zorcaine(Primacaine) Market Size and Volume Forecast by Type
12.7.1. Articaine and Epinephrine 1:100,000
12.7.2. Articaine and epinephrine 1:200,000
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Zorcaine(Primacaine) Demand Share, 2019-2026
13. Middle East & Africa Zorcaine(Primacaine) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Zorcaine(Primacaine) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Zorcaine(Primacaine) Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Dental Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Zorcaine(Primacaine) Market Size and Volume Forecast by Type
13.7.1. Articaine and Epinephrine 1:100,000
13.7.2. Articaine and epinephrine 1:200,000
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Zorcaine(Primacaine) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Zorcaine(Primacaine) Market: Market Share Analysis
14.2. Zorcaine(Primacaine) Distributors and Customers
14.3. Zorcaine(Primacaine) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Septodont
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Acteon Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. COMPANY3
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
